348 related articles for article (PubMed ID: 15090951)
1. Alcoholic povidone-iodine to prevent central venous catheter colonization: A randomized unit-crossover study.
Parienti JJ; du Cheyron D; Ramakers M; Malbruny B; Leclercq R; Le Coutour X; Charbonneau P;
Crit Care Med; 2004 Mar; 32(3):708-13. PubMed ID: 15090951
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Goudet V; Timsit JF; Lucet JC; Lepape A; Balayn D; Seguin S; Mimoz O
Trials; 2013 Apr; 14():114. PubMed ID: 23782845
[TBL] [Abstract][Full Text] [Related]
5. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
[TBL] [Abstract][Full Text] [Related]
6. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
[TBL] [Abstract][Full Text] [Related]
7. Skin antisepsis for reducing central venous catheter-related infections.
Lai NM; Lai NA; O'Riordan E; Chaiyakunapruk N; Taylor JE; Tan K
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010140. PubMed ID: 27410189
[TBL] [Abstract][Full Text] [Related]
8. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.
Langgartner J; Linde HJ; Lehn N; Reng M; Schölmerich J; Glück T
Intensive Care Med; 2004 Jun; 30(6):1081-8. PubMed ID: 15085323
[TBL] [Abstract][Full Text] [Related]
9. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison.
Girard R; Comby C; Jacques D
J Infect Public Health; 2012 Mar; 5(1):35-42. PubMed ID: 22341841
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J; Marjanovic N; Drugeon B; Neill RO; Liuu E; Roblot F; Palazzo P; Bironneau V; Prevost F; Paul J; Pichon M; Boisson M; Frasca D; Mimoz O;
Lancet Infect Dis; 2021 Jul; 21(7):1038-1048. PubMed ID: 33539734
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
13. Chlorhexidine versus povidone iodine in preventing colonization of continuous epidural catheters in children: a randomized, controlled trial.
Kinirons B; Mimoz O; Lafendi L; Naas T; Meunier J; Nordmann P
Anesthesiology; 2001 Feb; 94(2):239-44. PubMed ID: 11176087
[TBL] [Abstract][Full Text] [Related]
14. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study.
Pages J; Hazera P; Mégarbane B; du Cheyron D; Thuong M; Dutheil JJ; Valette X; Fournel F; Mermel LA; Mira JP; Daubin C; Parienti JJ;
Intensive Care Med; 2016 Sep; 42(9):1418-26. PubMed ID: 27311311
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
18. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
[TBL] [Abstract][Full Text] [Related]
19. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies.
Safdar N; Kluger DM; Maki DG
Medicine (Baltimore); 2002 Nov; 81(6):466-79. PubMed ID: 12441903
[TBL] [Abstract][Full Text] [Related]
20. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
